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Functional Status After Operation for Ebstein Anomaly
The Mayo Clinic Experience
Morgan L. Brown, MD,* Joseph A. Dearani, MD, FACC,* Gordon K. Danielson, MD, FACC,*
Frank Cetta, MD, FACC,†‡ Heidi M. Connolly, MD, FACC,‡ Carole A. Warnes, MD, FACC,†‡
Zhuo Li, MS,§ David O. Hodge, MS,§ David J. Driscoll, MD, FACC†
Rochester, Minnesota
Objectives The objective of this study was to review the long-term functional outcome of patients with Ebstein anomaly who
had cardiac operation at our institution.
Background Ebstein anomaly is a spectrum of tricuspid valvular and right ventricular dysplasia. Many patients will require
operation in an attempt to improve quality of life.
Methods From April 1, 1972, to January 1, 2006, 539 patients with Ebstein anomaly underwent 604 cardiac operations
at the Mayo Clinic in Rochester, Minnesota. Patient records were reviewed, and all patients known to still be
alive were mailed a medical questionnaire or contacted by telephone.
Results At the initial operation at our institution, the mean age of the patients was 24 years (range 8 days to 79 years)
and 53% were female patients. Survival at 5, 10, 15, and 20 years was 94%, 90%, 86%, and 76%, respectively.
Survival free of late reoperation was 86%, 74%, 62%, and 46% at 5, 10, 15, and 20 years, respectively. Surveys
were returned by 285 of 448 (64%) patients known to be alive at the time of this study. Two hundred thirty-seven
(83%) patients were in New York Heart Association functional class I or II, and 34% were taking no cardiac medica-
tion. One hundred three patients (36%) reported an incident of atrial fibrillation or flutter, 5 patients (2%) reported
having had endocarditis, and 1 patient (1%) reported having a stroke. There were 275 pregnancies among 82
women. The recurrence of congenital heart disease was reported in 9 of 232 (3.9%) liveborn children.
Conclusions Patients have good long-term survival and functional outcomes after undergoing surgery for Ebstein anomaly.
Atrial arrhythmias are common both before and after surgery. Many patients have had one or more successful
pregnancies with a low-recurrence risk of congenital heart disease. (J Am Coll Cardiol 2008;52:460–6)
© 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.03.064f
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cbstein anomaly is a spectrum of tricuspid valvular (TV)
nd right ventricular (RV) dysplasia (1). Morbidity and
ortality are thought to be related to the degree of TV
egurgitation, the size, thickness, and function of the RV,
nd the presence or absence of an atrial septal defect (ASD).
See page 467
atients with mild forms of Ebstein anomaly may live
ormal life-spans, but many will require surgery. We have
eported mortality and reoperation rates for 539 patients
ho underwent operation at the Mayo Clinic (2). However,
ecause of the length and complexity of that paper, the
rom the Divisions of *Cardiovascular Surgery, †Pediatric Cardiology, ‡Cardiovas-
ular Diseases, and §Biostatistics, Mayo Clinic Center Congenital Heart Center,
ayo Clinic College of Medicine, Mayo Clinic and Foundation, Rochester,
innesota.r
Manuscript received January 22, 2008; revised manuscript received February 25,
008, accepted March 3, 2008.unctional status of these patients was not included in that
eport. Hence, the purpose of this report is to assess the
ong-term functional outcome and reproduction of patients
ith Ebstein anomaly who required operation.
ethods
atients. From April 1, 1972, to January 1, 2006, 539
atients with Ebstein anomaly had an operation at the
ayo Clinic by 1 of 2 surgeons (G.K.D. and J.A.D.). Of
he 448 patients not known to be deceased, we were able to
btain current information for 285 patients (64%). These
atients form the basis of this report (Fig. 1). Excluded from
his cohort were patients with pulmonary atresia with intact
entricular septum, complex conotruncal abnormalities, or
trioventricular discordance with ventriculoarterial discor-
ance (“congenitally corrected transposition”).
ndications for surgery. The indications for surgery in-
luded 1 or more of the following: symptoms of dyspnea or
ight heart failure (New York Heart Association [NYHA]
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August 5, 2008:460–6 Functional Status and Operation for Ebstein Anomalyunctional class III or IV), progressive exercise intolerance,
achyarrhythmias not controllable by medication or amenable
o catheter-based intervention, and significant associated le-
ions, including ASDs, ventricular septal defects, or pulmonary
tenosis. In some patients, progressive cardiomegaly, a cardio-
horacic ratio0.65, severe cyanosis, and reduced left ventric-
lar (LV) function were indications for surgery (2).
ata collection. Two of the investigators (M.L.B. and
.J.D.) collected all pertinent data from the medical record
2). These data included all follow-up information regarding
eoperation and deaths that had been received from non-Mayo
linic health care providers. Before mailing surveys, we deter-
ined the vital status of patients by using all medical records
vailable and through Accurint (LexisNexus, Philadelphia,
ennsylvania), a commercial database.
Detailed health status questionnaires were mailed to all
articipants who were thought to be alive. Patients who did
ot return or complete the questionnaire were sent a second
uestionnaire. If the second questionnaire was not returned
r completed, attempts were made to contact the patient by
elephone. Questionnaires were sent to 468 patients, and 20
f these patients were found to be deceased. Of the 448
atients not known to be deceased, questionnaires were
eturned and Health Insurance Portability and Accountabil-
ty Act (i.e., HIPAA) forms completed by 285 (64%)
atients (Table 1).
tatistical analysis. Patients were placed into 1 of 3 groups
ased on their late functional outcome: excellent, good, and
oor. Patients who were determined to have an excellent
utcome were required to fulfill all of the following at late
ollow-up: described their health as excellent or good,
eported no current cardiac symptoms, described no hospi-
alizations for heart or heart-related problems, rated their
bility to exercise relative to other people the same age as the
ame or greater, and were employed despite their heart
ondition. Patients were classified as a poor outcome if they
eported any one of the following: unable to walk up one
ight of stairs without resting, were unemployed or only
539 patients
had an operation at
Mayo Clinic
285 returned 
surveys (64%)
58 patients (11.5%) died
during follow-up
448 patients 
not known to be 
deceased
33 patients (6.1%) 
died 30 days 
after operationFigure 1 Patient Cohort Studied
Hmployed part time because of
heir heart condition, or under-
ent reoperation. The remaining
atients were placed in a good
utcome group.
When comparing patient char-
cteristics between patients who
esponded to the survey and those
ho did not, the Fisher exact test
r chi-square test was used to
ompare categorical variables
hereas the 2-sample t test or
ilcoxon rank sum test was used to compare continuous
ariables where appropriate. Univariate and multivariate
ogistic models with the use of SAS version 9.1 (SAS
nstitute, Cary, North Carolina) were created to identify
redictors of functional outcome. Patients were grouped
nto 2 categories for these models: excellent/good and poor
utcome. Univariate and multivariate predictors of reopera-
ion and rehospitalization were determined with log-rank
ests and Cox proportional hazard models. Multivariate Cox
egression models were built based on univariately signifi-
ant variables (p  0.05) with a stepwise selection method.
his method constructs a model by evaluating all factors
nd selecting the most significant factor. That factor is
ntered, and all other factors are evaluated, adjusting for the
ntered variable. This process continues until no other
actors are significant after adjusting for the variables in the
odel. Kaplan-Meier curves were drawn for any reopera-
ion, reoperation on TV, and rehospitalization. Only
-tailed probability values were reported; p  0.05 was
onsidered significant.
We assessed variables including, among others, patient
ge at operation, year of operation, surgeon, patient gender,
atient age at diagnosis, cardiothoracic ratio on chest x-ray,
resence and type of preoperative arrhythmia, rhythm on
lectrocardiogram, blood oxygen saturation (oximetry), he-
oglobin, hematocrit, and previous cardiac procedures (for
complete list and definitions, see the Online Appendix).
ssociated cardiac defects and type of operation (including
V repair, TV replacement, and miscellaneous concomitant
rocedures) were also included.
Echocardiographic variables included pre-operative and
ost-operative RV size and function, degree of TV stenosis
nd or regurgitation, degree of pulmonary valve stenosis or
uestionnaires
Table 1 Questionnaires
Questionnaires n  468
Responded 285
Unable to contact: foreign, unlisted, physical or mental barrier 49
Nonresponse 43
Questionnaire completed but no HIPAA form completed 43
Refusal 28
Found to be deceased 20
Abbreviations
and Acronyms
ASD  atrial septal defect
LV  left
ventricle/ventricular
NYHA  New York Heart
Association
RV  right ventricle/
ventricular
TV  tricuspid valveIPAA  Health Insurance Portability and Accountability Act.
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Functional Status and Operation for Ebstein Anomaly August 5, 2008:460–6egurgitation, degree of mitral valve stenosis or regurgita-
ion, and LV ejection fraction. The degree of TV regurgi-
ation, RV or LV dysfunction, and RV or LV enlargement
ere graded as none, mild, moderate, moderate-to-severe,
nd severe by the use of transthoracic echocardiography. If
variable was present in fewer than 5 patients, it was not
onsidered in the analysis.
In the entire cohort (n  539), the initial operation at
ayo Clinic was TV repair for 182 patients, TV replace-
ent for 337 patients, and a variety of nonvalve operations
or 20 patients. Survival and reoperation have previously
een reported (2). We included in the rubric of “functional
utcome”: the need for reoperation, the presence of cardiac
ymptoms, NYHA functional classification, cardiac-related
ospitalizations, perceived exercise limitation, ongoing need
or cardiac medication, the presence of arrhythmia, and
eproductive ability.
esults
atient characteristics. Patients who responded to the
urvey (n  285) were compared with patients who did not
eturn the survey but who were known to be alive (n 185).
atients who did not return the survey were more likely to
ave moderate-to-severe to severe reduced pre-operative
V function (p  0.002, chi-square test). Responders
ere more likely to have had their first operation at Mayo
linic at a later date (mean year 1994 vs. 1993, p  0.017).
xcept for these factors, the groups were similar.
urvival free of reoperation. For the 285 long-term sur-
ivors who completed the Health Status Questionnaire the
-, 5-, 10-, 15-, and 20-year survival and freedom from any
eoperation (on the TV or other cardiac operation) were
7%, 91%, 82%, 72%, and 56%, respectively. In a multivar-
ate model, age 12 years at operation was associated with
reater freedom from reoperation. Hypoplastic or stenotic
ulmonary arteries or need for intraaortic balloon pump
Figure 2 Freedom From Any Reoperation in
Patients Who Responded to Survey Questionnaires
Time zero is the first operation at Mayo Clinic. The number of patients was 285.ost-operatively was associated with increased risk for
eoperation (Fig. 2, Table 2).
rediction of functional status. On the basis of the 285
atients who completed and returned the Health Status
uestionnaires, 43% of the patients were in NYHA func-
ional class I, 40% in class II, 12% in class III, and 4% were
n class IV. One percent did not respond to the questions
egarding functional status. One-half of the subjects reported
hat their exercise tolerance was equal to or greater than their
eers (Fig. 3, Table 3).
After classifying patients as outlined in the Methods
ection, 21 (7.4%) patients had an excellent outcome, 206
72.3%) had a good outcome, and 58 had a poor outcome
20.4%). In a multivariate model, later year of operation and
0
2
4
6
8
10
12
14
16
18
20
1 2 3 4 5 6 7 8 9 10
Activity Scale 
1=less active 10=more active
%
 o
f 
p
a
ti
e
n
ts
Figure 3 Self-Reported Activity Scale
After Operation for Ebstein Anomaly
Shown are the percentage of survey responders who rated their
exercise tolerance related to other people their own age on a scale of 1 to 10.
nivariate and Multivariateredictors of Any Reoperation
Table 2 Univariate and MultivariatePredictors of Any Reoperation
Hazard
Ratio p Value
Univariate predictors
Younger age at first operation at Mayo (12 yrs) 3.56 0.001
Younger age at diagnosis (4 yrs) 2.56 0.001
Later date of operation (per 10 yrs) 1.62 0.030
Pulmonary valve stenosis greater than mild 3.66 0.021
Abnormal pulmonary artery architecture 6.58 0.001
Any previous cardiac procedure 2.10 0.007
Previous systemic-pulmonary artery shunt 3.86 0.001
Previous cavopulmonary shunt 7.13 0.001
Closure of shunt 3.07 0.003
Low cardiac output state post-operatively 3.32 0.008
Intraaortic balloon pump post-operatively 5.94 0.006
Respiratory insufficiency post-operatively 4.60 0.001
Renal insufficiency post-operatively 6.32 0.004
Multivariate predictors
Younger age at first operation at Mayo (12 yrs) 3.23 0.001
Abnormal pulmonary artery architecture 3.50 0.004
Intraaortic balloon pump post-operatively 12.27 0.001
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August 5, 2008:460–6 Functional Status and Operation for Ebstein Anomalyight reduction atrioplasty were associated with excellent or
ood functional outcomes, and previous cardiac operation
nd pre-operative history of arrhythmia were associated
ith a poor outcome (Table 4). Whether the tricuspid
alve was repaired or replaced at the first operation at
ayo Clinic had no effect on the patients’ functional
lassification (p  0.30).
elf-reported symptoms. Early fatigue and shortness of
reath were reported by slightly more than one-third of the
esponders. Close to 40% of patients reported a history of
achyarrhythmias (Table 5).
ardiac medications. Eighty-four of 251 patients (34%)
ere taking no cardiac medications. Digoxin was the most
ommon cardiac medication (taken by 22% of patients)
ollowed by warfarin (taken by 20% of patients) and furo-
emide (taken by 16% of patients) (Table 6).
ubsequent hospitalizations. The reasons for all hospital-
zations at any hospital subsequent to operation at the Mayo
linic are recorded in Table 7 for the 285 respondents to
he medical status questionnaire. Freedom from rehospital-
zation for cardiac causes, including reoperation of any type,
as 91%, 79%, 68%, 53%, and 35% at 1, 5, 10, 15, and 20
ears, respectively. Multivariate analysis demonstrated that
ge 12 years at time of operation, later date of operation,
revious cavopulmonary shunt insertion, need for post-
perative intraaortic balloon pump, pre-dismissal thrombus
n the right atrium or on the TV, the need for a permanent
acemaker, and a more than moderate enlargement of the
V on pre-dismissal echocardiography were predictive of
elf-Reported Exercise Tolerance
Table 3 Self-Reported Exercise Tolerance
My Ability of Exercise Relative to Peers Is n  285 %
Much greater 7 2.5
Slightly greater 29 10.2
About the same 105 36.8
Slightly less 89 31.2
Much less 43 15.1
I am unable to exercise 5 1.8
Unknown 7 2.5
nivariate and Multivariate Predictorsr Excell nt/Indetermin o Poor Outcomes
Table 4 Univariate and Multivariate Predictorsor Excellent/Indeterminate or Poor Outcomes
Odds Ratio p Value
Univariate predictors
Earlier year of operation (210 yrs) 1.50 0.041
Any previous cardiac procedure 2.11 0.016
Right reduction atrioplasty 0.50 0.037
Previous history of a specific arrhythmia 2.24 0.009
Multivariate predictors (all risk factors)
Right reduction atrioplasty 0.51 0.045
Previous history of a specific arrhythmia 2.23 0.11
Multivariate predictors (only pre-operative risk
factors)
Earlier year of operation (210 yrs) 1.72 0.004ehospitalization. The most common cause for readmission
o hospital was an arrhythmia. Five patients reported hos-
italization for infectious endocarditis; 3 patients had pre-
ious TV replacement (2 bioprosthetic, 1 mechanical) and 2
ad previous TV repair. We were unable to determine
hether all cases had positive blood cultures.
eproduction and inheritance. A total of 82 of the 109
emale respondents reported at least 1 pregnancy (Table 8).
efore undergoing surgery, 59 women had a total of 140
regnancies and, after surgery, 27 women had 62 pregnan-
ies. The miscarriage rate before surgery was 19% and after
urgery was 33%. There were 232 liveborn children: 88 to
athers and 144 to mothers with Ebstein anomaly. Nine of
he liveborn children were reported to have a heart defect; 6
ere born to mothers and 3 were born to fathers with
bstein anomaly. The cardiac abnormalities in the children
ere tricuspid atresia, atrial fibrillation, patent ductus arte-
iosus, “hole in heart” (that was surgically closed), Down
yndrome with complete atrioventricular septal defect, an
ymptoms Reported by 285 Survey Responders
Table 5 Symptoms Reported by 285 Survey Responders
Symptom
Total
(n  285) %
Early fatigue 120 42.1
Palpitations 111 38.9
Your doctor told you that you had tachycardias 106 37.2
Your doctor told you that you had atrial flutter/fibrillation 103 36.1
Shortness of breath 87 30.5
Abnormally rapid heart rate 74 26.0
Ankle or leg swelling 41 14.4
Your doctor told you that you had bradycardia 35 12.3
Chest pain 30 10.5
Your doctor told you that you had ventricular tachycardia 26 9.1
Your doctor told you that you had premature ventricular
contractions
27 9.5
Abdominal fluid retention 23 8.1
Abnormally slow heart rate 20 7.0
Fainting 7 2.5
edications Indicated by Survey Responders
Table 6 Medications Indicated by Survey Responders
Cardiac Medications Total (n  285) %
None 97 34.0
Digoxin 62 21.8
Warfarin 56 19.6
Furosemide 45 15.8
Angiotensin-converting enzyme inhibitor 25 8.8
Spironolactone 16 5.6
Beta-blocker 16 5.6
Amiodarone 16 5.6
Unspecified diuretic 9 3.2
Verapamil 8 2.8
Thiazide diuretic 7 2.5
Quinidine 3 1.1
Procainamide 1 0.4
Norpace 2 0.7Any previous cardiac procedure 2.68 0.003 Other cardiac medication 121 42.5
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Functional Status and Operation for Ebstein Anomaly August 5, 2008:460–6nspecified “valve problem,” mitral valve prolapse, Ebstein
nomaly, and ASD.
iscussion
eoperation. Ebstein anomaly is a complex congenital
bnormality involving both the TV and RV and may require
urther hospitalization or reoperation after the original
perative repair. Symptomatic arrhythmias continue to be a
roblem in a significant number of patients. However,
atients’ perception of their exercise capability is similar to
heir peers.
Reoperation for patients with Ebstein anomaly and sig-
ificant TV dysfunction remains a long-term issue for
atients after TV repair or replacement. For the entire
ohort of 539 patients, the 10- and 20-year survival free
rom any reoperation was 74% and 46% (2), and for the 285
uestionnaire respondents in this study, it was 82% and
6%. For the 285 questionnaire respondents, the 10-, 15-,
nd 20-year freedom from reoperation on the TV was 92%,
4%, and 68%, respectively, for patients who had TV repair
t their initial surgery and 82%, 70%, and 56%, respectively,
or patients who had TV replacement at their initial surgery
t Mayo Clinic. The rates of reoperation for patients who
ad a TV repair or replacement were not statistically
ifferent among questionnaire respondents. Innovations in
alve repair techniques should be continued to develop more
urable results. For valves that cannot be repaired, more
urable biological valves and less thrombotic mechanical
alves must be sought.
ospitalizations. Hospitalizations are common even after
peration. Reoperation for TV dysfunction is a reality after
easons for Subsequent Hospitalization After First Operation at Ma
Table 7 Reasons for Subsequent Hospitalization After First Ope
Reason for Hospitalization
Admission
#1
Admission
#2
A
Arrhythmia 59 (21) 22 (11)
Heart failure 9 (3) 3 (1)
Endocarditis 5 (2) 0
Stroke 1 (1) 0
Cardiac transplantation 1 (1) 0
Pacemaker or implantable cardiac-defibrillator 14 (5) 11 (4)
Abdominal swelling 4 (1) 2 (1)
Leg swelling 9 (3) 3 (1)
Valve repair/replacement 21 (7) 11 (4)
Other heart surgery 11 (4) 11 (4)
regnancies Reported by 82 of 285 Respondents
Table 8 Pregnancies Reported by 82 of 285 Respondents
Time of Pregnancy Women, n Pregnancies, n Miscarriages,
Before operation 59 140 27 (19)
After operation 27 62 21 (33)
Total 86 202 48Children of affected men and women.ither TV repair or replacement for many patients. How-
ver, arrhythmias were the most common reason for hospi-
alization (39%), underscoring their importance in these
atients. Efforts to reduce the frequency of post-operative
achyarrhythmias require further investigation and may
nclude: 1) earlier operation to prevent excessive enlarge-
ent of the right heart chambers; 2) routine addition of the
aze procedure; and 3) manipulation of atrial incisions to
educe the likelihood of re-entrant rhythms. Interestingly,
e found that a later date of operation was associated with
ehospitalization, which may be related to referral bias,
ecall bias, or changes in medical practice.
ymptoms and functional status. In the current study,
ore that one-third of patients continued to have subjective
atigue and shortness of breath. This finding is not surpris-
ng because patients with Ebstein anomaly have a myo-
athic RV (3). These patients often continue to have some
lements of RV enlargement and dysfunction. Also, many
f these patients have had significant cardiomegaly, which
an have detrimental effects on lung growth and pulmonary
unction. Right ventricular dilation may displace the inter-
entricular septum and compress the LV, thus impairing
V function.
Atrial tachyarrhythmias are a common ongoing problem
or patients with Ebstein anomaly, even after operation. In
he current study, approximately one-third of patients re-
orted palpitations and showed evidence of supraventricular
achycardia after operation. Previously, we reported (4) that
he incidence of supraventricular tachycardia was signifi-
antly lower early after operation for Ebstein anomaly, but
ith longer follow-up, the number of patients experiencing
linic as Reported by Survey Responders
n at Mayo Clinic as Reported by Survey Responders
No. of Hospitalizations, n (%)
ion Admission
#4
Admission
#5
Admission
#6
Admission
#7
Admission
#8
) 9 (3) 6 (2) 2 (1) 1 (1) 1 (0)
) 3 (1) 1 (1) 0 0 0
0 0 0 0 1 (1)
0 0 0 0 0
1 (1) 2 (1) 0 0 0
) 3 (1) 3 (1) 2 (1) 2 (1) 0
1) 1 (1) 1 (1) 0 0 0
0 0 0 0 0
) 2 (1) 0 0 0 0
) 5 (2) 3 (1) 2 (1) 1 (1) 2 (1)
Therapeutic Abortions, n
Liveborn Children, n*
Affected Father Affected Mother
22 57 101
3 31 43
25 88 144yo C
ratio
dmiss
#3
13 (5
4 (1
0
0
0
12 (4
1 (
0
5 (2
6 (2n (%)
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August 5, 2008:460–6 Functional Status and Operation for Ebstein Anomalyupraventricular tachyarrhythmias increases. This finding is
ot unexpected, because the vast majority of these patients
ad chronically distended right atria and, after operation,
ad surgical scars on the right atrium. Thus, control of
upraventricular tachyarrhythmias remains a challenge in
hese patients.
Previously, we reported the results of formal exercise
esting for a very small subset of our patients (5,6). In those
tudies, there was a significant improvement in exercise
olerance in patients after they underwent surgery for
bstein anomaly; this improvement resulted mainly from
limination of the right-to-left shunt at the atrial level. In
he current study, exercise tolerance was assessed with the
edical status questionnaire. It is apparent from Figure 2
hat the patients’ perceived exercise ability was distributed in
Gaussian fashion around the mean. There are limitations
o this type of survey, most importantly the lack of a control
roup and incomplete ascertainment of information.
edications. Only 34% of patients were taking no cardiac
edications after operation. Although one might suggest
hat the need for continued use of medication may indicate
less-than-optimal result of operation, it must be remem-
ered that operation does not cure the cardiomyopathy
omponent of Ebstein anomaly. The ongoing use of med-
cation is appropriate for patients with abnormal ventricular
unction and with post-operative arrhythmia; it also is
ppropriate for the prevention of thromboembolic events.
e recommend systemic anticoagulation for the few pa-
ients who had insertion of a mechanical valve and for
atients with persistent atrial fibrillation. We use systemic
nticoagulation for 3 months post-operatively after insertion
f a bioprosthesis in the tricuspid position.
eproduction and inheritance. The miscarriage rate for
ur patients was 19% before operation and 33% after opera-
ion, which is comparable to the miscarriage rate in the general
opulation of 13.7% to 26.1% (7,8). In the second Natural
istory Study of Congenital Heart Defects (9), the miscarriage
ate for women with aortic stenosis, pulmonary stenosis, or
entricular septal defect was 12.8%, 13.7%, and 21.1%, respec-
ively. Recently, Drenthen et al. (10) reported a miscarriage
ate for women with Ebstein anomaly of 18% and that 3.9% of
27 pregnancies were complicated by arrhythmias and 3.1% by
eart failure.
We recorded a total of 275 pregnancies among 82
omen (Table 8). The incidence of congenital heart
isease in children of a parent with Ebstein anomaly was
.9%, which is significantly greater than the expected
ncidence of 0.75% in the general population. However, it
s nearly identical to the incidence in Ebstein anomaly
eported by Drenthen et al. (10) of 4% and previous
eports from our institution (11). In addition, it is
onsistent with the incidence in children born to a parent
ith aortic stenosis, pulmonary stenosis, or ventricular
eptal defect (1.2% to 3.9%, 95% confidence interval:
.01% to 7.5%) (10).tudy limitations. In this study, we hoped to identify the
eterminants of poor outcome and the determinants of
ood outcome. Intuitively, and based upon previous small
tudies, one might suggest that RV size and function as
ell as LV function and other measures of severity of TV
ysplasia would correlate with outcome. Because our
tudy is retrospective, we had to use echocardiographic
ata obtained during a 33-year period. These data were
ot collected in a uniform fashion. Measurement of RV
ize and function remains difficult with the use of
chocardiography. Also, because of leftward displace-
ent of the ventricular septum, which often is associated
ith paradoxical septal motion, it is difficult to know the
mplications of estimated LV ejection fraction. Despite
hese caveats, RV size and both RV and LV function are
mportant determinants of outcome. Improved measure-
ents of ventricular size and function, such as could be
btained with magnetic resonance imaging, may increase
he usefulness of ventricular size and function in predict-
ng outcome.
Survivors who did not return a health questionnaire
ad a statistically significant greater likelihood of greater
han moderate RV dysfunction post-operatively (p 
.002). This finding may have skewed the functional
utcomes findings toward more positive results. Finally,
espite the availability of classifications of anatomic
ubtypes of Ebstein anomaly (12), we were unable to
etrospectively classify most patients. We did include
chocardiographic measurements of severity and repara-
ility. These measurements were not statistically signifi-
ant predictors in any of our analyses.
onclusions
he functional outcome after operation for Ebstein
nomaly is good, and reported exercise tolerance is
omparable with patients’ peers. Reoperation, rehospital-
zation, and atrial tachyarrhythmias continue to be prob-
ematic. Assessment of the late results of novel methods
o repair the TV is required. A more durable biological
rosthesis is needed for patients whose valves are irrep-
rable. Continued efforts to reduce the occurrence of
trial arrhythmias in patients with Ebstein anomaly are
ritical.
eprint requests and correspondence: Dr. David J. Driscoll,
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APPENDIX
or a list of the primers used for PCR and sequencing
f E-catenin, please see the online version of this article.
